I am not that knowledgable myself. But about the vaccines, my understanding is that they are not that effective and that distributing them is very expensive. The vaccines require a cold chain, multiple doses spread well apart, and the vaccine is delivered as an injection. These are all major obstacles to cost-effective distribution in a developing country setting, so while some might say that “progress is slower than it should be”, personally I have pretty low expectations.
These questions came up as I read for this post, and I’d love to hear answers from more knowledgeable people:
How will insecticide-resistant mosquitoes affect the populations protected by insecticide-treated malaria nets?
How are the vaccine rollouts going? Are the vaccines showing the efficacy which pilot results suggested?
I am not that knowledgable myself. But about the vaccines, my understanding is that they are not that effective and that distributing them is very expensive. The vaccines require a cold chain, multiple doses spread well apart, and the vaccine is delivered as an injection. These are all major obstacles to cost-effective distribution in a developing country setting, so while some might say that “progress is slower than it should be”, personally I have pretty low expectations.
Thanks! For a point of hope, R21 (the newer vaccine) apparently has “less strict” cold-chain requirements.